- Record: found
- Abstract: found
- Article: not found
Appropriate bolus administration of glycoprotein IIb/IIIa inhibitors for patients with acute coronary syndromes undergoing percutaneous coronary intervention: intracoronary or intravenous? A comprehensive and updated meta-analysis and systematic review.
Sadeq Ali-Hasan-Al-Saegh
1 ,
Seyed Jalil Mirhosseini ,
Arezoo Shahidzadeh ,
Elham Rahimizadeh ,
Zahra Sarrafan-Chaharsoughi ,
Zahra Ghodratipour ,
Mohammad Lotfaliani ,
Mohammad Rezaeisadrabadi ,
Hamid Reza Dehghan ,
Christian Bireta ,
Alexander Weymann ,
Anton Sabashnikov ,
Aron-Frederik Popov
2016
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
This systematic review with meta-analysis sought to compare the efficacy and safety of intracoronary (IC) vs. intravenous (IV) administration of glycoprotein (GP) IIb/IIIa receptor inhibitors on clinical outcomes following per-cutaneous coronary intervention in patients with acute coronary syndromes (ST-segment elevation myocardial infarction or non-ST-segment-elevation acute coronary syndrome).